Mariano Bizzarri – författare
2 389 kr
Skickas inom 10-15 vardagar
1 977 kr
Läs direkt efter köp
Systems Biology
1 631 kr
Skickas inom 10-15 vardagar
Biomedicine and Biotechnology in Space
Molecular Methods
2 238 kr
Skickas inom 10-15 vardagar
2 822 kr
Läs direkt efter köp
1 631 kr
Skickas inom 10-15 vardagar
1 977 kr
Läs direkt efter köp
This volume focuses on methodological aspects of systems biology in order to provide a new theoretical approach with a robust and tailored experimental support. Chapters detail mathematical modeling, methodological issues, modulation of the collective behavior, metabolic, dynamic profiling, and quantitative morphological studies. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.
Authoritative and practical, Systems Biology aims to ensure successful results in the further study of this vital field.
1 631 kr
Skickas inom 10-15 vardagar
1 634 kr
Skickas inom 10-15 vardagar
2 036 kr
Läs direkt efter köp
This volume – for pharmacologists, systems biologists, philosophers and historians of medicine – points to investigate new avenues in pharmacology research, by providing a full assessment of the premises underlying a radical shift in the pharmacology paradigm. The pharmaceutical industry is currently facing unparalleled challenges in developing innovative drugs. While drug-developing scientists in the 1990s mostly welcomed the transformation into a target-based approach, two decades of experience shows that this model is failing to boost both drug discovery and efficiency. Selected targets were often not druggable and with poor disease linkage, leading to either high toxicity or poor efficacy. Therefore, a profound rethinking of the current paradigm is needed. Advances in systems biology are revealing a phenotypic robustness and a network structure that strongly suggest that exquisitely selective compounds, compared with multitarget drugs, may exhibit lower than desired clinical efficacy. This appreciation of the role of polypharmacology has significant implications for tackling the two major sources of attrition in drug development, efficacy and toxicity. Integrating network biology and polypharmacology holds the promise of expanding the current opportunity space for druggable targets.
1 634 kr
Skickas inom 10-15 vardagar